T

Tennessee Oncology

Community-based cancer care with clinical research

Early Phase Clinical Research Nurse

Full-TimeUpdated on 10/23/2026
No salary listed
Senior
Bachelor of Science (BS), Associate of Science (AS)
Nashville, TN, USA
In PersonMay support clinical research activities at other Tennessee Oncology research locations as needed.
Biology & BiotechClinical Research Operations

About the job

Requirements
  • An active Registered Nurse license in Tennessee and/or Georgia is required.
  • A Bachelor of Science in Nursing is preferred, or an Associate Degree in Nursing from an accredited nursing program will be considered based on relevant clinical and research experience.
  • Five years of clinical nursing experience and at least one year of research or oncology nursing experience are required.
  • ONS Chemotherapy-Immunotherapy certification is required at hire or within three months of hire.
  • AHA or ARC Basic Life Support certification is required at hire or within three months of hire.
  • Knowledge of medical and research terminology is required.
  • Knowledge of FDA Code of Federal Regulations and Good Clinical Practice is required.
Responsibilities
  • Coordinate and provide comprehensive nursing care to participants enrolled in early phase oncology clinical trials from screening through treatment and long-term follow-up.
  • Review study protocols, treatment plans, eligibility criteria, assessment schedules, and safety requirements to ensure accurate execution of protocol-specific activities.
  • Collaborate with the Principal Investigator and delegated investigators to evaluate participant eligibility, clinical status, treatment readiness, and ongoing participation in clinical trials.
  • Serve as the primary contact for assigned early phase research participants from informed consent through study completion.
  • Screen and assess potential research participants with the investigator and research team to determine eligibility under protocol-specific inclusion and exclusion criteria.
  • Facilitate informed consent and enroll eligible participants in accordance with protocol, regulatory, and institutional requirements.
  • Educate participants about study requirements, treatment expectations, investigational products, potential risks and benefits, medication administration, required procedures, and when to contact the research team.
  • Perform comprehensive and focused nursing assessments appropriate to the study and participant’s clinical condition.
  • Obtain and document protocol-required vital signs, weight, height, oxygen saturation, pain assessments, performance status, and other clinical assessments.
  • Monitor participants before, during, and after investigational treatment for adverse events, treatment-related toxicities, infusion or hypersensitivity reactions, and other changes in clinical condition.
  • Recognize and promptly communicate clinically significant findings to the Principal Investigator, delegated investigator, and appropriate research team members.
  • Identify, assess, document, and follow up on adverse events, serious adverse events, and other safety findings in accordance with protocol and regulatory requirements.
  • Ensure timely Principal Investigator or delegated investigator review and assessment of clinically significant findings and safety events.
  • Review scheduled and unscheduled participant encounters, including emergency department visits, hospitalizations, and outside medical records, to identify potential adverse events, concomitant medications, and other clinically relevant information requiring follow-up.
  • Coordinate and perform protocol-required clinical procedures within scope of practice, including venipuncture, electrocardiograms, specimen collection, port access, infusion-related activities, and other study-specific procedures.
  • Administer investigational products and supportive medications as permitted by licensure, protocol requirements, institutional policy, and delegation of authority.
  • Access implanted vascular access devices and establish peripheral intravenous access as appropriate.
  • Collect protocol-required laboratory specimens and ensure proper handling, processing, and shipment according to protocol requirements.
  • Conduct and coordinate pharmacokinetic, pharmacodynamic, and other protocol-required research assessments, including biological specimen collection at precise protocol-defined time points.
  • Perform and document protocol-required calculations, including body surface area, creatinine clearance, dose calculations, dose modifications, urine protein-to-creatinine ratios, and other study-specific calculations.
  • Monitor patients for infusion reactions, adverse events, dose-limiting toxicities, and other treatment-related complications.
  • Review and reconcile participant medications and maintain accurate documentation of concomitant medications and medication changes throughout study participation.
  • Educate participants about investigational and supportive medications, including dosage, administration, storage, adherence, potential side effects, and required reporting of missed doses or adverse symptoms.
  • Monitor investigational product compliance and accountability in collaboration with pharmacy and research staff as applicable.
  • Coordinate protocol-required laboratory testing, imaging, procedures, appointments, and follow-up visits to ensure completion within required study windows.
  • Maintain accurate, complete, contemporaneous, and attributable source documentation for participant encounters, assessments, procedures, treatments, and clinical findings.
  • Enter clinical and research data accurately and on time into the electronic medical record, electronic data capture systems, and other applicable research databases.
  • Apply Good Clinical Practice, ALCOA/ALCOA+ principles, HIPAA, Human Subjects Protection requirements, and applicable regulatory standards to research activities and documentation.
  • Identify and appropriately escalate protocol deviations, safety concerns, missed assessments, out-of-window procedures, and unresolved clinical or research-related issues.
  • Collaborate with clinical research coordinators, physicians, advanced practice providers, pharmacists, laboratory personnel, pathologists, sponsors, clinical research associates, and other multidisciplinary research team members.
  • Serve as a primary clinical resource for research participants and coordinate communication between participants, investigators, and the research team.
  • Participate in sponsor monitoring visits, audits, inspections, quality assurance activities, and other study-related activities as required.
  • Assist with study start-up, including protocol review, study-specific training, development of clinical workflows, and preparation of clinical areas and research materials.
  • Maintain current knowledge of assigned protocols and communicate protocol amendments, safety updates, and changes in study requirements to appropriate team members.
  • Maintain required certifications and training in Good Clinical Practice, Human Subjects Protection, chemotherapy/biotherapy, biological specimen handling and shipping, and other study-specific requirements.
  • Complete required study-specific training, continuing education, and competency validations within established timelines.
  • Participate in research meetings, staff meetings, committees, quality improvement initiatives, and educational programs as requested.
  • Support clinical research activities at other Tennessee Oncology research locations as needed.
  • Maintain participant confidentiality and comply with HIPAA, institutional policies, Tennessee Oncology standards, and applicable federal, state, and regulatory requirements.
  • Demonstrate the Tennessee Oncology Code of Conduct, mission, values, professionalism, and commitment to patient-centered research.
  • Perform other duties and responsibilities as assigned in support of the clinical research program.
Desired Qualifications
  • Knowledge of clinical research processes.
  • Knowledge of investigational therapies, infusion monitoring, adverse event assessment, vascular access, protocol-specific procedures, and time-sensitive research assessments.
  • ACRP/CCRP certification.
  • Oncology Certified Nurse (OCN) certification.

About the company

Tennessee Oncology runs a large network of community-based cancer care with a strong clinical-trial program. It delivers cancer treatment at local clinics, including on-site chemotherapy, and uses molecular diagnostics to tailor therapies to each patient’s cancer. The organization supports patients with its in-house Park Pharmacy, which stocks oncology and hematology medications and handles insurance, prior authorizations, co-pays, and 24/7 pharmacist access. It differentiates itself by combining extensive community-based care with a sizable research network and a partnership with OneOncology, enabling broad access to trials and advanced care at convenient locations. The goal is to provide high-quality cancer care and access to clinical research close to patients’ homes.

Company Size

501-1,000

Company Stage

Debt Financing

Total Funding

$98.3M

Headquarters

Nashville, Tennessee

Founded

1976

Get referred to Tennessee Oncology

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • August 2026 Tullahoma opened 33,000 square feet, expanding local cancer access.
  • February 2026 OncoveryCare expanded survivorship coverage across all solid tumors network-wide.
  • March 2025 CMO Casey Chollet-Lipscomb and 321 active jobs signal continuing operational investment.

What critics are saying

  • A 2025 FCA probe alleged supervision and documentation failures; DOJ declined, but scrutiny persists.
  • Cencora bought OneOncology in February 2026, increasing strategic dependence and integration risk.
  • Major builds in Chattanooga, Tullahoma, and Murfreesboro strain operations; a physician defections wave would cripple coverage.

What makes Tennessee Oncology unique

  • Tennessee Oncology runs 90-plus sites across Tennessee and North Georgia, anchored in community care.
  • Its July 2025 Nashville flagship packs oncology, imaging, Park Pharmacy, and research together.
  • Greco-Hainsworth Centers for Research and thousands of trials create a durable clinical-edge moat.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Paid Vacation
  • Flexible Work Hours

Growth & Insights and Company News

6 month growth

10%

1 year growth

10%

2 year growth

10%
The Daily Times
Oct 16th, 2026
More than 500 attend annual Senior Expo for health information, community connections and fellowship.

More than 500 attend annual Senior Expo for health information, community connections and fellowship. * Staff Reports * Oct 15, 2026 Hundreds of seniors gathered Wednesday at First Baptist Church of Maryville for the 2026 Grand Times Senior Expo, taking advantage of free health screenings, information about Medicare and senior services, and an opportunity to socialize. The event, organized by The Daily Times for the eighth consecutive year, featured vendors offering products and services geared toward older adults. Many attendees have made the expo an annual tradition. "It's always interesting to see new products and maybe companies I use that I don't see all the time," said Boni Witt. John Keeble and his wife, Connie, have attended the expo for four years. Both had straightforward answers when asked what keeps them coming back. "Meeting friends," John said. "To get your (flu) shot and the information you get every year," Connie said. Brian Cox accompanied his mother, Barbara Cox, to the event and took advantage of free flu shots provided by Blount Discount Pharmacy. "I'm her bodyguard," Brian joked. "Everybody's friendly and it's easy to communicate with them," Barbara said. Vendors also expressed satisfaction with the turnout. Participants included banks, Medicare insurance agents, hospitals, clinics, pharmacies and other businesses providing products and services for seniors. Myra Hedrick, an Avon representative, participated as a vendor for the fifth year. "I like just seeing all the people and getting to talk," Hedrick said. "It's wonderful. It's great to meet all the community of Blount County, especially the seniors," said Jill Dell of Asbury Ridge Senior Living in Maryville. "They have a great place in my heart and Asbury's heart." Amber Stevens of Tennessee Oncology in Alcoa participated for the second year. "I think it's a great opportunity for us to connect and be with our community members," Stevens said. "A lot of times, we don't get outside our clinic so to be able to get out and see this population and community is a privilege for us and we enjoy fellowshiping with them." Darrell Hull, a new nurse practitioner with Tennessee Oncology, agreed. "It's a magnificent event," Hull said. "This is a huge turnout and for the community to come out to an event like this is great. It gives us an opportunity to meet the people in the community. I've already talked to people who have already been to our clinic and family members who have already been to our clinic. It's that putting the face with the name. It really solidifies us with the community." Darren Haimer, general manager of The Daily Times, credited vendors and community partners for the event's success. "I want to thank all of our vendors for participating in the Grand Times Senior Expo and for everything they do for our community," Haimer said. "We also appreciate Maryville's own Richy Kreme for providing complimentary donuts. More than 500 people attended, which was a phenomenal turnout, and the vendor support was just as strong. We've been proud to host this event, and we look forward to many more years to come."

Brands Review Magazine
Aug 4th, 2026
Tennessee Oncology opens state-of-the-art Medical Center in Tullahoma.

Tennessee Oncology opens state-of-the-art Medical Center in Tullahoma. Tennessee Oncology, which treats nearly half the cancer patients in the Volunteer state, recently opened its new Tullahoma Medical Center, a state-of-the-art medical facility located at 2230 N. Jackson Street. Situated on a three-acre campus in Tullahoma's north commercial gateway, the 33,000-square-foot center brings together medical oncology, radiation oncology and imaging services under one roof, providing patients with comprehensive cancer care close to where they live and work. The new center expands access to advanced cancer treatments and diagnostic services, reducing the need for patients to travel outside the Tullahoma region to receive care. "As Tennessee Oncology celebrates its 50th anniversary of caring for patients across our state, I can't think of a better example of our commitment to bringing world-class cancer care close to home than the opening of our new cancer center in Tullahoma," said Natalie Dickson, MD, president and CEO of Tennessee Oncology. "By bringing multiple services together in one location, we're making care more coordinated, easier to navigate and more accessible for patients and their families. This new facility represents a significant investment in the health and future of the Tullahoma community." The medical oncology teams consists of Ryan Carr MD, Dr. Nnamdi Eze MD, and Brian Schlick, MD. The radiation oncologists caring for patients in Tullahoma include Andrew Camarata, MD, MBA, who is Board Certified in Radiation Oncology, and Lauren Kropp MD, who is the latest radiation oncologist to join Tennessee Oncology's growing Tullahoma-based team. Tennessee Oncology extends its sincere appreciation to the City of Tullahoma, the local business community, Precise Construction, Grace Herbert Curtis Architects, and Johnson Development for their support and partnership in bringing this project to life. To celebrate the opening of the new center as a symbol of hope, healing and the enduring strength of the Tullahoma community, Tennessee Oncology will host a community open house on Monday, Aug. 31, from 5 p.m. to 7 p.m. "The Tullahoma Medical Center is a continuation of the incredible legacy of Dr. Mainuddin Ahmed and Dr. Adil Mohyuddin, whose dedication to cancer care in this region laid the foundation for this new center," Dr. Dickson said. "Their commitment created a culture of excellence that has brought world-class cancer care to patients in Tullahoma for decades, and we are honored to build upon that legacy."

PR Newswire
Aug 3rd, 2026
Tennessee Oncology opens 33,000-square-foot Tullahoma cancer centre

Tennessee Oncology has opened a new medical centre in Tullahoma, Tennessee. The 33,000-square-foot facility at 2230 N. Jackson Street consolidates medical oncology, radiation oncology, and imaging services on a three-acre campus. The centre aims to reduce the need for patients to travel outside the Tullahoma region for cancer treatment. Tennessee Oncology treats nearly half of the state's cancer patients. The practice, which is celebrating its 50th anniversary, will host a community open house on 31 August from 5 p.m. to 7 p.m. The medical team includes oncologists Ryan Carr, Nnamdi Eze, and Brian Schlick, along with radiation oncologists Andrew Camarata and Lauren Kropp.

TN Oncology
Aug 3rd, 2026
Tennessee Oncology opens new state-of-the-art Tullahoma Medical Center.

Tennessee Oncology opens new state-of-the-art Tullahoma Medical Center. Tennessee Oncology, which treats nearly half the cancer patients in the Volunteer state, today - Monday, August 3, 2026 - opened its new Tullahoma Medical Center, a state-of-the-art medical facility located at 2230 N. Jackson Street. Situated on a three-acre campus in Tullahoma's north commercial gateway, the 33,000-square-foot center brings together medical oncology, radiation oncology and imaging services under one roof, expanding access to advanced cancer treatments and diagnostic services so patients can receive more of their care close to where they live and work. "As Tennessee Oncology celebrates its 50th anniversary of caring for patients across our state, I can't think of a better example of our commitment to bringing world-class cancer care close to home than the opening of our new comprehensive cancer center in Tullahoma," said Natalie Dickson, MD, president and CEO of Tennessee Oncology. "By bringing multiple services together in one location, we're making care more coordinated, easier to navigate and more accessible for patients and their families. This new facility represents a significant investment in the health and future of the Tullahoma community." The new center will be staffed by Tennessee Oncology's established medical oncology team - Drs. Ryan Carr, Nnamdi Eze, and Brian Schlick - who have long served patients throughout the Tullahoma community and will relocate their practice to the new facility. The center will also bring together Tennessee Oncology's radiation oncology services under one roof, led by Dr. Andrew Camarata and Dr. Lauren Kropp, who recently joined Tennessee Oncology. Together, the multidisciplinary team will provide seamless, comprehensive cancer care in a single, state-of-the-art location close to home. Tennessee Oncology extends its sincere appreciation to the City of Tullahoma, the local business community, Precise Construction, Grace Herbert Curtis Architects, and Johnson Development for their support and partnership in bringing this project to life. To celebrate the opening of the new center as a symbol of hope, healing and the enduring strength of the Tullahoma community, Tennessee Oncology will host a community open house on Monday, Aug. 31, from 5 p.m. to 7 p.m. "The Tullahoma Medical Center is a continuation of the incredible legacy of Dr. Mainuddin Ahmed and Dr. Adil Mohyuddin, whose dedication to cancer care in this region laid the foundation for this new center," Dr. Dickson said. "Their commitment created a culture of excellence that has brought world-class cancer care to patients in Tullahoma for decades, and we are honored to build upon that legacy." About Tennessee Oncology | Tennessee Oncology, one of the nation's largest community-based cancer care practices, is home to one of the leading clinical trial networks in the country. Established 1976 in Nashville, Tennessee Oncology's mission remains unchanged: To provide access to high-quality cancer care and the expertise of clinical research for all patients, at convenient locations within their community and close to their home. Its growing network of physicians and locations is based on this mission. For more information, visit www.tnoncology.com. Media contact: Eric Hoffman ([email protected])

TN Oncology
Jun 8th, 2026
Executing a major renovation around cancer care: how Tennessee Oncology is giving its downtown Chattanooga office a major facelift.

Executing a major renovation around cancer care: how Tennessee Oncology is giving its downtown Chattanooga office a major facelift. Tennessee Oncology, which treats nearly half the cancer patients in the Volunteer State, opened the newly-renovated lobby today and began construction on the second and third floors at its downtown Chattanooga clinic, located at 1032 McCallie Ave., as part of a two-year overhaul. Renovating an operational oncology clinic requires expertise so that patient care is not disrupted and the project build-out can be staged efficiently. Tennessee Oncology is partnering with Blevins Construction and Tinker Ma to double the overall size of the clinic, including: * Expanding patient check-in and check-out areas * Doubling the infusion room space * Tripling the exam and new patient consult rooms * Increasing the laboratory, pharmacy, and research pharmacy areas * Adding an administrative suite "Tennessee Oncology has deep roots in the Chattanooga community, and we're excited to unveil our newly renovated lobby and welcome patients and their families into a space designed to enhance the patient experience," said Natalie Dickson, MD, CEO and President of Tennessee Oncology. "As our practice has grown throughout the state, we've learned valuable lessons in how to expand without interrupting patient care. I'm proud of how our care teams ensured their patients' needs were met throughout the first phase of construction and look forward to the project's completion." At the downtown Chattanooga clinic, six physicians and six advanced practice providers care for patients. Throughout the renovation, Tennessee Oncology's clinical and operational teams will work closely to ensure uninterrupted access to care while construction progresses in phases around active patient treatment areas. The renovation reflects Tennessee Oncology's long-term commitment to the Chattanooga community and will provide patients, caregivers, and staff with a significantly expanded and modernized facility designed to support continued growth, enhance the patient experience, and increase access to high-quality cancer care for years to come. About Tennessee Oncology | Tennessee Oncology, one of the nation's largest community-based cancer care practices, is home to one of the leading clinical trial networks in the country. Established 1976 in Nashville, Tennessee Oncology's mission remains unchanged: To provide access to high-quality cancer care and the expertise of clinical research for all patients, at convenient locations within their community and close to their home. Its growing network of physicians and locations is based on this mission. For more information, visit www.tnoncology.com. Media contact: Eric Hoffman ([email protected])